Company Profile
Augmedix Stock Price, News & Analysis
- Ticker:
- AUGX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
AUGX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Augmedix is a healthcare technology company focused on ambient documentation and clinical workflow support for providers. Its business is about reducing administrative burden rather than developing therapies.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Augmedix sits in digital health and healthcare IT.
Business Model Characteristics
The company depends on software adoption, enterprise contracts, and the economics of physician workflow automation.
Position Within the Biotechnology Landscape
Augmedix is outside biotech and belongs to the healthcare-software and workflow layer.
Future catalysts
Augmedix’s catalysts are AI-scribing adoption, enterprise retention, and whether hospital workflow demand stays strong. The market will care about product adoption rather than a binary scientific event.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
BRKR · Source: Bruker
- 02
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
DGX · Source: Quest Diagnostics
- 03
Molina Healthcare Reports Second Quarter 2026 Financial Results
MOH · Source: Molina Healthcare
- 04
Axon to Release Second Quarter 2026 Earnings on August 5, 2026
AXON · Source: Axon Enterprise, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Augmedix do?
Augmedix is a healthcare technology company focused on ambient documentation and clinical workflow support for providers. Its business is about reducing administrative burden rather than developing therapies.
On which exchange is AUGX stock listed?
Augmedix (AUGX) is associated with NASDAQ, United States, Biopharma.
What is Augmedix?
Augmedix’s catalysts are AI-scribing adoption, enterprise retention, and whether hospital workflow demand stays strong.
Which conditions is Augmedix targeting with Augmedix?
Augmedix’s catalysts are AI-scribing adoption, enterprise retention, and whether hospital workflow demand stays strong.
How does Augmedix describe recent progress with Augmedix?
Augmedix’s catalysts are AI-scribing adoption, enterprise retention, and whether hospital workflow demand stays strong.
What is AI-scribing?
Augmedix’s catalysts are AI-scribing adoption, enterprise retention, and whether hospital workflow demand stays strong.
What should investors watch for with AI-scribing?
Augmedix’s catalysts are AI-scribing adoption, enterprise retention, and whether hospital workflow demand stays strong.
What future catalysts are investors watching for Augmedix?
Augmedix’s catalysts are AI-scribing adoption, enterprise retention, and whether hospital workflow demand stays strong. The market will care about product adoption rather than a binary scientific event.